Advanced Oncotherapy (LON:AVO) issued its earnings results on Monday. The company reported GBX (9.83) (($0.12)) EPS for the quarter, missing analysts’ consensus estimates of GBX (8.90) (($0.11)) by GBX (0.93) (($0.01)), Bloomberg Earnings reports.
Shares of LON AVO remained flat at $GBX 26 ($0.32) during trading hours on Wednesday. The company had a trading volume of 345,853 shares, compared to its average volume of 79,755. The stock has a fifty day moving average price of GBX 26.61 and a two-hundred day moving average price of GBX 32.04. Advanced Oncotherapy has a twelve month low of GBX 20 ($0.25) and a twelve month high of GBX 44.50 ($0.55). The company has a current ratio of 2.16, a quick ratio of 0.79 and a debt-to-equity ratio of 55.71. The company has a market capitalization of $79.66 million and a P/E ratio of -1.86.
Advanced Oncotherapy Company Profile
Featured Article: What is intrinsic value?
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.